Patent: 6,130,248
✉ Email this page to a colleague
Summary for Patent: 6,130,248
Title: | Tricarboxylic acid-containing oxyalkyl esters and uses thereof |
Abstract: | This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating cutaneous ulcers, treating gastrointestinal disorders, treating blood disorders such as anemias, immunomodulation, enhancing recombinant gene expression, treating insulin-dependent patients, treating cystic fibrosis patients, inhibiting telomerase activity, treating virus-associated tumors, especially EBV-associated tumors, augmenting expression of a tumor suppressor gene and inducing tolerance to an antigen. The methods of the invention use tricarboxylic acid substituted oxyalkyl esters. |
Inventor(s): | Nudelman; Abraham (Rehovot, IL), Rephaeli; Ada (North Caldwell, NJ) |
Assignee: | Bar-ILAn University (Ramat-Gan, IL) Mor Research Applications, Ltd. (Givat Shmuel, IL) Beacon Laboratories, Inc. (Phoenix, MD) |
Application Number: | 08/781,905 |
Patent Claims: | see list of patent claims |
Details for Patent 6,130,248
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |